Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1561765

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1561765

Global Cough Remedies Market Size Study, By Product Type, By Age Group, By Distribution Channel, and Regional Forecasts 2022-2032

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

The Global Cough Remedies Market is valued at approximately USD 7.83 billion in 2023 and is projected to grow with a steady CAGR of 3.9% over the forecast period 2024-2032. Cough, an immune response triggered by the respiratory system to combat foreign bodies or harmful antigens, remains one of the most common symptoms associated with a wide range of respiratory conditions. These conditions, which include tobacco use, postnasal drip, asthma, and gastroesophageal reflux disease (GERD), can lead to chronic cough if left untreated, potentially causing significant complications such as lung congestion.

The growth of the Global Cough Remedies Market is driven by several factors. A surge in the geriatric population, who are more susceptible to cough and cold, combined with increasing pollution levels, has amplified the demand for effective cough remedies. Additionally, the rise in demand for over-the-counter (OTC) products, ongoing advancements in R&D, and heightened awareness about advanced medicinal solutions are expected to bolster market growth in the coming years. Furthermore, the expansion of testing and research facilities, particularly within the biotechnology and pharmaceutical sectors, contributes to the market's positive outlook. However, the market faces challenges, including stringent regulations surrounding the efficacy of cough remedies, which may impede growth. Despite these hurdles, the market is poised to benefit from new opportunities, particularly as the prevalence of respiratory conditions continues to rise, creating a fertile ground for innovation in cough treatment solutions.

The key regions considered in the study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. The Asia-Pacific region held the largest revenue share in 2020 and is expected to maintain its dominance, supported by a growing population, increased healthcare expenditure, and rising awareness about respiratory health. Additionally, the LAMEA region is anticipated to register the fastest growth during the forecast period, driven by improving healthcare infrastructure and increasing investments in healthcare services.

Major market players included in this report are:

  • Novartis International AG
  • Bayer AG
  • Pfizer, Inc.
  • Procter & Gamble (P&G)
  • Reckitt Benckiser Group plc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • AstraZeneca plc
  • Sun Pharmaceuticals Industries Limited
  • Prestige Brands, Inc.
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Boehringer Ingelheim GmbH
  • Mylan N.V.
  • Takeda Pharmaceutical Company Limited

The detailed segments and sub-segments of the market are explained below:

By Product Type:

  • Expectorants
  • Bronchodilators
  • Decongestants
  • Antibiotics

By Age Group:

  • Pediatric
  • Adult

By Distribution Channel:

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

By Region:

North America:

  • U.S.
  • Canada

Europe:

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific:

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Latin America:

  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of the geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of the competitive structure of the market.
  • Demand-side and supply-side analysis of the market.

Table of Contents

Chapter 1. Global Cough Remedies Market Executive Summary

  • 1.1. Global Cough Remedies Market Size & Forecast (2022- 2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product Type
    • 1.3.2. By Age Group
    • 1.3.3. By Distribution Channel
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Cough Remedies Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Cough Remedies Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rising Incidence of Respiratory Conditions
    • 3.1.2. Increasing Demand for Over-the-Counter Products
  • 3.2. Market Challenges
    • 3.2.1. Strict Regulatory Compliance
    • 3.2.2. Limited Efficacy of Traditional Remedies
  • 3.3. Market Opportunities
    • 3.3.1. Technological Advancements in Cough Treatment
    • 3.3.2. Rising Geriatric Population
    • 3.3.3. Growth in R&D Activities

Chapter 4. Global Cough Remedies Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunity
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Cough Remedies Market Size & Forecasts by Product Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Cough Remedies Market: Expectorants Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.3. Global Cough Remedies Market: Bronchodilators Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.4. Global Cough Remedies Market: Decongestants Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.5. Global Cough Remedies Market: Antibiotics Revenue Trend Analysis, 2022 & 2032 (USD Billion)

Chapter 6. Global Cough Remedies Market Size & Forecasts by Age Group 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Cough Remedies Market: Pediatric Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.3. Global Cough Remedies Market: Adult Revenue Trend Analysis, 2022 & 2032 (USD Billion)

Chapter 7. Global Cough Remedies Market Size & Forecasts by Distribution Channel 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Cough Remedies Market: Retail Pharmacy Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 7.3. Global Cough Remedies Market: Hospital Pharmacy Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 7.4. Global Cough Remedies Market: Online Pharmacy Revenue Trend Analysis, 2022 & 2032 (USD Billion)

Chapter 8. Global Cough Remedies Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Cough Remedies Market
    • 8.1.1. U.S. Cough Remedies Market
      • 8.1.1.1. Product Type breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Age Group breakdown size & forecasts, 2022-2032
      • 8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Cough Remedies Market
    • 8.1.3. Mexico Cough Remedies Market
  • 8.2. Europe Cough Remedies Market
    • 8.2.1. U.K. Cough Remedies Market
    • 8.2.2. Germany Cough Remedies Market
    • 8.2.3. France Cough Remedies Market
    • 8.2.4. Italy Cough Remedies Market
    • 8.2.5. Spain Cough Remedies Market
    • 8.2.6. Rest of Europe Cough Remedies Market
  • 8.3. Asia-Pacific Cough Remedies Market
    • 8.3.1. China Cough Remedies Market
    • 8.3.2. India Cough Remedies Market
    • 8.3.3. Japan Cough Remedies Market
    • 8.3.4. Australia Cough Remedies Market
    • 8.3.5. South Korea Cough Remedies Market
    • 8.3.6. Rest of Asia-Pacific Cough Remedies Market
  • 8.4. Latin America Cough Remedies Market
    • 8.4.1. Brazil Cough Remedies Market
    • 8.4.2. Saudi Arabia Cough Remedies Market
    • 8.4.3. South Africa Cough Remedies Market
    • 8.4.4. Rest of Latin America Cough Remedies Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Novartis International AG
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. IVAX Paper Chemicals
    • 9.3.3. Faran Shimi
    • 9.3.4. AdooQ Bioscience LLC
    • 9.3.5. Sun Pharmaceutical Industries Ltd.
    • 9.3.6. Sanofi S.A.
    • 9.3.7. Freedom Pharmaceuticals
    • 9.3.8. Ascent Scientific
    • 9.3.9. Teva Pharmaceutical Industries Ltd.
    • 9.3.10. Mallinckrodt Pharmaceuticals
    • 9.3.11. Olympus Corporation
    • 9.3.12. Alkermes plc
    • 9.3.13. Hikma Pharmaceuticals
    • 9.3.14. Pfizer Inc.
    • 9.3.15. Endo International plc

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!